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Absence of response of prolactin to hypoglycaemia induced by insulin in obese children Kopelman et al found thiat in adults with a history of obesity from early childhood there was no response of plasma prolactin concentration to symptomatic hypoglycaemia induced by intravenous injection of insulin. 1 2 In contrast, release of prolactin was unimpaired in patients in whom the obesity had occurred either during teenage years or later. These findings suggested that in obese children there should be no response of prolactin to induced hypoglycaemia. We carried out a study to test this.
Subjects, methods, and results
We studied six obese children aged 4-13 and five obese adults aged 23-38 whose mean (SD) body weight was 127-2 (7-9)0O and 147-0 (30 8)°o of the ideal, respectively. Seven non-obese children aged 6-12 and 11 non-obese adults aged 19-23 were also studied as controls. Endocrinological examination of the 11 obese subjects yielded normal results. Five of the six obese children had a family history of obesity in their mother or father, or both. Obesity in the five adults had ensued after adolescence. In all subjects the response of plasma prolactin concentration to hypoglycaemia was monitored at 0, 15, 30, 45, 60, 90, and 120 minutes after an intravenous injection of insulin (0-1 units/kg body weight). The blood glucose concentration 30 minutes after administration of insulin in each subject decreased to less than half the basal concentration for that subject and was lower than 2-8 mmol/l (50 mg/100 ml).
Plasma prolactin concentrations were measured by radioimmunoassay.
The response of plasma prolactin concentration to stimulation by thyrotrophin releasing hormone (500 t'g) intravenously was normal in six obese children. The response patterns of plasma prolactin concentration to the induced hypoglycaemia were within normal limits in the obese adults and non-obese adults and children but not in the obese children, in whom figure) . As the highest mean percentage occurred in the obese adults and nonobese adults and children 45 minutes after the insulin was administered we compared the mean percentage at 45 minutes in obese children with that in the three other groups. The mean percentage in the obese children was significantly lower than that in the non-obese children (p < 001), obese adults (p < 0-05), and non-obese adults (p < 0 02) (Student's t test).
Comment
Hypoglycaemia normally acts via the hypothalamus to increase secretion of prolactin by the pituitary. Our findings indicate that this mechanism is disturbed in obese children. Cutaneous manifestations of zinc deficiency during treatment with anticonvulsants Two primary zinc deficiency states occur in man-namely, endemic nutritional zinc deficiency and acrodermatitis enteropathica, an inherited defect of zinc absorption.' Symptomatic secondary zinc deficiency is rare and has occurred after total parenteral nutrition and jejunoileal bypass operations and in chronic alcoholism.' To our knowledge it has not been reported in patients receiving anticonvulsants or in ulcerative colitis per se. Zinc deficiency produces widespread disturbances in growth, behaviour, and gastrointestinal function.' Skin manifestations include an erosive anogenital dermatitis and a condition similar to seborrhoeic dermatitis of the face with candidal cheilitis. In chronic deficiency well demarcated scaly red-brown plaques develop over bony prominences.
Case reports CASE 1 In 1983 a 37 year old subnormal epileptic woman presented with a nonitchy rash on one hand of two weeks' duration, which was In August 1983 a mentally subnormal epileptic man aged 28 presented with a one month history of a condition similar to seborrhoeic dermatitis of the face and neck, angular cheilitis, and a brownish-red, well demarcated scaly rash on the dorsum of both hands overlying the knuckles (figure). His lifelong Typical lesions of acrodermatitis enteropathica with scaly rash similar to seborrhoea around nasolabial folds, chin, and neck associated with candidal angular cheilitis. Rash on dorsum of left hand appeared over bony prominences of metacarpophalangeal and proximal interphalangeal joints. refractory epilepsy had been treated with phenobarbitone, phenytoin, and carbamazepine until 1979 when high dose sodium valproate had been substituted for phenytoin. In 1982 he had developed severe ulcerative colitis that was difficult to control because of poor compliance, and he had required several hospital admissions.
In 1983, despite intensive inpatient treatment, diarrhoea was uncontrollable and the rash, typical of acrodermatitis enteropathica, developed. Serum zinc concentration was 3 .mol/l (20 ,ug/l00 ml) and serum albumin concentration 32 g/l. After two weeks' treatment with intravenous zinc sulphate and parenteral nutrition the rash had resolved and the serum zinc concentration was normal. His recovery was complicated by septicaemia due to Staphylococcus aureus, but his ulcerative colitis became well controlled. Sodium valproate was continued for his epilepsy with oral zinc supplements; relapse did not occur.
Diagnosis of zinc deficiency is difficult and usually rests on the clinical picture and response to zinc treatment. No ideal laboratory tests are yet available, and measurement of the serum zinc concentration is probably the most useful. Whether a correction should be made for serum albumin concentration is debatable.
Lowered serum zinc concentrations during anticonvulsant treatment have been reported by several workers,2 but others have found concentrations to be unchanged.3 Chelation of zinc by phenytoin4 and sodium valproate5 in the gut is thought to occur, producing increased uptake but increased urinary excretion of zinc. Binding of zinc in the serum may decrease its free availability.
As zinc deficiency is rare and anticonvulsant treatment common we postulate that the deficiency in these cases occurred as a result of chelation of zinc by sodium valproate and possibly phenytoin in combination with malabsorption. In case 1 the malabsorption was initiated by sodium valproate, and presumably as symptoms of zinc deficiency developed the process became self perpetuating. In case 2 malabsorption occurred as a result of ulcerative colitis and zinc deficiency undoubtedly accounted for failure to control the colitis. Randomised trial of intravenous high dose metoclopramide and intramuscular chlorpromazine in controlling nausea and vomiting induced by cytotoxic drugs High dose metoclopramide given by intermittent intravenous infusion is one of the best antiemetics for the treatment of emesis induced by cytotoxic drugs.' This method of administration, however, produces fluctuating plasma concentrations and can lead to accumulation of the drug with the risk of toxicity.2 A continuous intravenous infusion overcomes this fluctuation and, as the antiemetic effect of metoclopramide is related to its plasma concentration,3 may also enhance the drug's antiemetic properties. Chlorpromazine is a widely used antiemetic and has not been compared with high dose metoclopramide in the control of emesis. It is effective when administered intramuscularly and thus presents less of a logistic problem in delivery than high dose metoclopramide.
Patients, methods, and results
Ninety five patients (52 women, 43 men; mean age 49) received their first course of chemotherapy, which consisted of regimens containing cisplatin or cisplatin analogues in 43 and regimens without cisplatin in 52. Patients were randomly assigned either antiemetic by a double blind, double dummy technique. Metoclopramide was given as a 50 mg loading dose intravenously 30 minutes before chemotherapy, followed by a 12 hour intravenous infusion of 5 mg/kg in 500 ml physiological saline. Chlorpromazine 25 mg (1 ml) was given intramuscularly every four hours for 12 hours, beginning with the chemotherapy. Nausea and vomiting were recorded for the 24 hours after the end of chemotherapy, and patients assessed control of emesis on a linear
